论文部分内容阅读
本文对67例膀胱移行细胞癌(TCC)患者术前行血和尿癌胚抗原(SCEA、UCEA)测定,27例膀胱部分切除术者及5例膀胱全切除术者行术后SCEA和UCEA测定,经病理分级分期,且与正常组比较。术前Ⅰ级Ⅰ期患者SCEA、UCEA值与正常组无显著性差异,Ⅱ级Ⅱ期以上者均较正常组明显增高(P<0.01),膀胱部分切除术后各级期SCEA值与正常组无显著性差异(P>0.05),Ⅰ级Ⅰ期UCEA与正常组无差异(P>0.05),Ⅱ级Ⅱ期以上者术后UCEA值与正常组相比仍呈高度显著性差异(P<0.01),膀胱全切除术后SCEA、UCEA值恢复正常。提示,TCC行膀胱部分切除术后UCEA的监测对TCC患者的预后有重要意义。
In this study, SCEA and UCEA were measured in 67 cases of TCC before operation and 27 cases of partial cystectomy and 5 cases of total cystectomy. , Staging by pathology, and compared with the normal group. There was no significant difference in SCEA and UCEA between preoperative stage Ⅰ and stage Ⅰ, level Ⅱ and Ⅱ were significantly higher than those in normal group (P <0.01). After SCT, There was no significant difference between the two groups (P> 0.05). There was no significant difference between the UCEA group Ⅰ and the normal group (P> 0.05), while there was still a significant difference between the UCEA group and the normal group (P < 0.01). After total cystectomy, SCEA and UCEA values returned to normal. Tip, TCC bladder partial resection UCEA monitoring of prognosis of patients with TCC is of great significance.